SHAREHOLDER ALERT: LB KPTI EGBN MDP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, Sept. 19, 2019 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies.

Metadata

Provider:

GlobeNewswire, Inc.

Retrieved on:

Thursday, September 19, 2019

Information

Tags:

Manufactured goods, Private Securities Litigation Reform Act, Goods economics), Wire, Kernel page-table isolation

Geotags:

NEW YORK, Us

Organisation:

THE LAW OFFICES OF VINCENT WONG

Summary

Key Points:

NEW YORK, Sept. 19, 2019 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies.
If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Get additional information about KPTI: http://www.wongesq.com/pslra-1/karyopharm-therapeutics-inc-loss-submissi...
Get additional information about EGBN: http://www.wongesq.com/pslra-1/eagle-bancorp-inc-loss-submission-form?wi...
Get additional information about MDP: http://www.wongesq.com/pslra-1/meredith-corporation-loss-submission-form...
To learn more contact Vincent Wong, Esq.
is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights.

NEW YORK, Sept. 19, 2019 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

L Brands, Inc. (NYSE: LB)
Lead Plaintiff Deadline: September 23, 2019
Class Period: May 31, 2018 and November 19, 2018

Get additional information about LB: http://www.wongesq.com/pslra-1/l-brands-inc-loss-submission-form?wire=3

Karyopharm Therapeutics Inc (NASDAQGS: KPTI)
Lead Plaintiff Deadline: September 23, 2019
Class Period: on behalf of shareholders who: (i) purchased shares of Karyopharm’s securities between March 2, 2017 and February 22, 2019, inclusive (ii) purchased Karyopharm shares in or traceable to the Company’s public offering of common stock conducted on or around April 28, 2017; or (iii) purchased Karyopharm shares in or traceable to the Company’s public offering of common stock conducted on or around May 7, 2018.

Get additional information about KPTI: http://www.wongesq.com/pslra-1/karyopharm-therapeutics-inc-loss-submissi...

Eagle Bancorp, Inc. (NASDAQ: EGBN)
Lead Plaintiff Deadline: September 23, 2019
Class Period: March 2, 2015 and July 17, 2019

Get additional information about EGBN: http://www.wongesq.com/pslra-1/eagle-bancorp-inc-loss-submission-form?wi...

Meredith Corporation (NYSE: MDP)
Lead Plaintiff Deadline: November 5, 2019
Class Period: January 31, 2018 and September 5, 2019

Get additional information about MDP: http://www.wongesq.com/pslra-1/meredith-corporation-loss-submission-form...

To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]